Biomarkers for the Assessment of Stroke/Systemic Embolism and Bleeding Risk in Patients With Atrial Fibrillation: A Nested Observational Study From ENGAGE AF-TIMI 48

被引：0

作者：

Berg, David D. ^{[1
]}

Ruff, Christian T. ^{[1
]}

Jarolim, Petr ^{[2
]}

Giugliano, Robert P. ^{[1
]}

Nordio, Francesco ^{[1
]}

Lanz, Hans J. ^{[3
]}

Mercuri, Michele ^{[4
]}

Grosso, Michael ^{[5
]}

Antman, Elliott M. ^{[1
]}

Braunwald, Eugene ^{[1
]}

Morrow, David A. ^{[1
]}

机构：

[1] Brigham & Womens Hosp, Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Pathol, 75 Francis St, Boston, MA 02115 USA

[3] Dauchi Sankyo, Global Med Affairs, Munich, Germany

[4] Daiichi Sankyo, Pharma Dev, Basking Ridge, NJ USA

[5] Daiichi Sankyo, Cardiovasc Clin Dev, Basking Ridge, NJ USA

来源：

CIRCULATION | 2018年 / 138卷

关键词：

Atrial fibrillation; Biomarkers; Stroke; Anticoagulation;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A14367

引用

页数：2

共 50 条

[21] Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial
Boriani, Giuseppe
Ruff, Christian T.
Kuder, Julia F.
Shi, Minggao
Lanz, Hans J.
Antman, Elliott M.
Braunwald, Eugene
Giugliano, Robert P.
THROMBOSIS AND HAEMOSTASIS, 2021, 121 (02) : 140 - 149
[22] The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic Substudy
Gupta, Deepak K.
Giugliano, Robert P.
Ruff, Christian T.
Claggett, Brian
Murphy, Sabina
Antman, Elliott
Mercuri, Michele F.
Braunwald, Eugene
Solomon, Scott D.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2016, 29 (06) : 537 - 544
[23] Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial
Steffel, J.
Giugliano, R. P.
Braunwald, E.
Murphy, S. A.
Atar, D.
Heidbuchel, H.
Camm, A. J.
Antman, E. M.
Ruff, C. T.
EUROPEAN HEART JOURNAL, 2015, 36 (33) : 2239 - 2245
[24] A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial
Fanola, Christina L.
Giugliano, Robert P.
Ruff, Christian T.
Trevisan, Marco
Nordio, Francesco
Mercuri, Michele F.
Antman, Elliott M.
Braunwald, Eugene
EUROPEAN HEART JOURNAL, 2017, 38 (12) : 888 - 896
[25] Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF-TIMI 48 Trial
Wang, Kaijun
Li, Haiyan
Kwong, Winghan J.
Antman, Elliott M.
Ruff, Christian T.
Giugliano, Robert P.
Cohen, David J.
Magnuson, Elizabeth A.
Vogelmann, O.
Gonzalez, C.
Ahuad Guerrero, R.
Rodriguez, M.
Albisu, J.
Rosales, E.
Allall, O.
Reguero, M.
Alvarez, C.
Garcia, M.
Ameriso, S.
Ameriso, P.
Amuchastegui, M.
Caceres, M.
Beloscar, J.
Petrucci, J.
Berli, M.
Budassi, N.
Valle, M.
Bustamante Labarta, G.
Saravia, M.
Caccavo, A.
Fracaro, V.
Cartasegna, L.
Novas, V.
Caruso, O.
Saa Zarandon, R.
Colombo, H.
Morandini, M.
Cuello, J.
Rosell, M.
Cuneo, C.
Bocanera, M.
D'Amico, A.
Cendali, G.
Dran, R.
Moreno, V.
Estol, C.
Davolos, M.
Facello, A.
Facello, M.
Falu, E.
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (08):
[26] Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation
Bergmark, Brian A.
Park, Jeong-Gun
Hamershock, Rose A.
Melloni, Giorgio E. M.
De Caterina, Raffaele
Antman, Elliott M.
Ruff, Christian T.
Rutman, Howard
Mercuri, Michele F.
Lanz, Hans-Joachim
Braunwald, Eugene
Giugliano, Robert P.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2024, 17 (07): : e010561
[27] Concomitant Use of Antiplatelet Therapy with Edoxaban or Warfarin in Patients with Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial
Xu, Haiyan
Ruff, Christian T.
Giugliano, Robert P.
Murphy, Sabina A.
Patel, Indravadan
Shi, Minggao
Mercuri, Michele
Antman, Elliott M.
Braunwald, Eugene
CIRCULATION, 2014, 130
[28] Edoxaban versus Warfarin in Patients With Atrial Fibrillation in the US FDA Approval Population: An Analysis From the ENGAGE AF-TIMI 48 Trial
Eisen, Alon
Giugliano, Robert P.
Ruff, Christian T.
Nordio, Francesco
Gogia, Harinder S.
Awasty, Vivek R.
Henderson, David A.
Mercuri, Michele
Rutman, Howard
Antman, Elliott M.
Braunwald, Eugene
CIRCULATION, 2015, 132
[29] Systemic, Non-cerebral, Arterial Embolism in 21,105 Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Results from the ENGAGE AF-TIMI 48 Trial
Geller, Bram J.
Ruff, Christian T.
Giugliano, Robert P.
Murphy, Sabina A.
Hanyok, James J.
Jin, Jianqing
Mercuri, Michele
Antman, Elliott M.
CIRCULATION, 2014, 130
[30] Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)
Link, Mark S.
Giugliano, Robert P.
Ruff, Christian T.
Scirica, Benjamin M.
Huikuri, Heikke
Oto, Ali
Crompton, Andrea E.
Murphy, Sabina A.
Lanz, Hans
Mercuri, Michele F.
Antman, Elliott M.
Braunwald, Eugene
Vogelmann, O.
Gonzalez, C.
Ahuad Guerrero, R.
Rodriguez, M.
Albisu, J.
Rosales, E.
Allall, O.
Reguero, M.
Alvarez, C.
Garcia, M.
Ameriso, S.
Ameriso, P.
Amuchastegui, M.
Caceres, M.
Beloscar, J.
Petrucci, J.
Berli, M.
Budassi, N.
Valle, M.
Bustamante Labarta, G.
Saravia, M.
Caccavo, A.
Fracaro, V.
Cartasegna, L.
Novas, V.
Caruso, O.
Saa Zarandon, R.
Colombo, H.
Morandini, M.
Cuello, J.
Rosell, M.
Cuneo, C.
Bocanera, M.
D'Amico, A.
Cendali, G.
Dran, R.
Moreno, V.
Estol, C.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2017, 10 (01)

← 1 2 3 4 5 →